AI-generated draft from CMS source. Review and verify clinical accuracy before use.
Authorization and Medical Necessity Workflow for CPT 64635 (Destruction by Neurolytic Agent, Lumbar or Sacral Facet Joint Nerve(s)):
1. Clinical Assessment and Diagnosis:
– Confirm diagnosis consistent with lumbar or sacral facet joint pathology (e.g., spondylosis or other specified dorsopathies).
– Use appropriate ICD-10 codes that best describe the patient’s condition (e.g., M47.816, M47.817, M53.86, M53.87).
– Documentation must include the assessment by the performing provider relevant to the patient complaint.
2. Conservative Care Requirement:
– Not clearly stated in source for CPT 64635 specifically; refer to LCD L38801 for detailed reasonable and necessary requirements.
– Obtain and document trial and failure of conservative treatments if indicated by LCD.
3. Diagnostic Confirmation:
– Pre-procedure diagnostic or therapeutic facet joint injections under fluoroscopy or CT guidance are generally required.
– Use codes 64493, 64494, or 64495 for diagnostic injections of lumbar/sacral facet joints.
– The KX modifier should be appended on diagnostic injection claims to indicate medical necessity per policy.
4. Procedural Details and Coding:
– CPT 64635 is for single-level neurolytic destruction performed with image guidance (fluoroscopy or CT).
– Each additional level requires use of 64636.
– Report unilateral or bilateral intervention with one unit; use modifier -50 for bilateral procedures.
– Ultrasound-guided procedures are not covered for these codes.
– Use proper modifiers and follow NCCI and OPPS rules for coding and billing.
5. Exclusion and Caution:
– Non-thermal or pulsed radiofrequency denervation should NOT be reported with these codes; CPT 64999 (non-covered) applies instead.
– Do not use sedation techniques such as moderate/deep sedation or general anesthesia routinely during injections; these are not considered reasonable unless clearly justified for RFA or cyst aspiration.
– Injection of biologicals or non-designated substances to the facet joint is non-covered and results in claim denial.
6. Documentation Requirements:
– Medical record should include:
• Detailed assessment correlating symptoms to lumbar/sacral facet joint.
• Relevant medical history.
• Results of diagnostic injections or tests.
• Signed and dated office visit notes or operative report.
• Explanation why patient is not a candidate for RFA if therapeutic injection is performed.
7. Note Language for Authorization or Audit:
Patient presents with chronic lumbar/sacral back pain consistent with facet joint pathology. Conservative treatments have been attempted without sufficient relief. Diagnostic facet joint injections under fluoroscopy confirmed the pain generator at the targeted facet joint(s). Based on clinical judgment and diagnostic findings, destruction of the lumbar/sacral facet joint nerve(s) using neurolytic agents is medically necessary. Patient is not a candidate for radiofrequency ablation due to [insert reason]. All procedures will be performed under fluoroscopic guidance per CMS guidelines. Documentation and clinical findings support the medical necessity for CPT code 64635.
This CMS article (A58403, version 25) from contractor/MAC provides billing and coding guidance specific to facet joint interventions for pain management, referencing Local Coverage Determination (LCD) L38801 version 23. The coverage focus is on cervical/thoracic and lumbar/sacral facet joint procedures performed with image guidance (fluoroscopy or CT) using CPT/HCPCS codes such as 64490-64495 for injections and 64633-64636 for neurolytic destruction. Ultrasound-guided injections and non-thermal denervation techniques are generally not covered under these CPT codes.
Covered ICD-10 codes primarily involve spondylosis and other specified dorsopathies without myelopathy or radiculopathy, across cervical, thoracic, lumbar, and sacral regions (e.g., M47.812-M47.897, M48.12-M48.17, M53.82-M53.87). No specific non-covered ICD-10s are identified. The article stresses that procedures should be reported per facet joint level (counting joints, not nerves), with unilateral or bilateral treatments documented accordingly using modifiers like -50 for bilateral services.
Important cautions include that biological or non-designated substances injected into facet joints will lead to claim denial. Use of moderate or deep sedation, general anesthesia, or monitored anesthesia care (MAC) during facet injections is generally not medically necessary and may trigger focused review, though sedation might be justified and documented for radiofrequency ablation (RFA) or facet cyst procedures.
Documentation requirements include the patient’s clinical assessment related to their complaint, relevant medical history, pertinent test results, and a signed and dated office visit or operative report. Referring or ordering physician details (name and NPI) must be included on claims if applicable, and claims without valid ICD-10 diagnosis codes describing the patient's condition will be returned as incomplete.
Providers should verify National Correct Coding Initiative (NCCI) edits and Outpatient Prospective Payment System (OPPS) packaging rules before billing. The CPT manual is the primary resource for code application details. This policy applies solely to facet joint procedures and excludes other spinal or joint interventions.
In summary, facet joint interventions for pain management using CPT codes 64490-64495 and 64633-64636 require careful adherence to LCD L38801 criteria, accurate ICD coding of spine-related diagnoses, appropriate use of modifiers, and thorough documentation to support medical necessity and billing compliance. Procedures with non-approved techniques or without proper documentation may be denied.